Gabby tried a variety of weight loss methods, without results. She also found out that because of her past health issues, she ...

LifeMD Inc. (NASDAQ: LFMD) is a leading telehealth provider operating an end-to-end virtual healthcare platform. LifeMD operates a direct-to-consumer (DTC) model focused on offering on-demand primary ...

LifeMD, Inc. announced its participation in several investor conferences throughout May 2025, including the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, the B. Riley ...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following ...

LifeMD, a leader in virtual healthcare services with a market capitalization of $346.54 million, reported its Q1 2025 earnings, showcasing a strong financial performance that exceeded market ...

LifeMD, a leader in virtual healthcare services with a market capitalization of $346.54 million, reported its Q1 2025 earnings, showcasing a strong financial performance that exceeded market ...

LifeMD LFMD is preparing to release its quarterly earnings on Tuesday, 2025-05-06. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect LifeMD to ...

Hims & Hers Health, LifeMD, Ro, and other platforms like them will now be able to sell Novo Nordisk's Wegovy, which is used for weight loss. The blockbuster GLP-1 should entice customers.

LifeMD's weight management program is one of the fastest-growing cash-pay offerings in the country, delivering virtual consultations, lab testing, diet and lifestyle support, and prescriptions to ...

LifeMD announced it will offer access to Wegovy through Novocare Pharmacy. The company will offer the weight-loss drug at a reduced self-pay price of $499 per month. Unlock your all-in-one trading ...